About the Summit
The 5th Annual mRNA-Based Therapeutics Summit is the premier international event for mRNA innovation, uniting 500+ leaders from biotech, pharma, and academia. The 2025 summit will spotlight the latest breakthroughs in:
-
mRNA design and engineering
-
IVT process optimization and dsRNA reduction
-
Novel delivery systems and capping strategies
-
Scalable GMP manufacturing
Event Details
š
Date: July 21ā23, 2025
š Location: Boston, MA, USA
šÆ Booth: Visit us at Booth 5
Come meet the Yeasen team to explore how our advanced solutions can support your mRNA therapeutic programs from discovery to GMP production.
Featured Products
LZCapā¢ AG(3āAcm) (GMP-Grade, High Affinity Cap1 Analog)
Designed for enhanced translation and expression
-
>97% capping efficiency
-
Strong eIF4E binding for improved translation
-
Higher protein output vs. traditional Cap1 analogs
-
Stabilized mRNA for therapeutic durability
An ideal choice for high-yield IVT and clinical mRNA applications.
Hieffā¢ T7 RNA Polymerase (Low dsRNA)
Engineered to minimize dsRNA without compromising yield
-
>10Ć lower dsRNA content
-
No need for additional dsRNA removal steps
-
Reduced innate immunogenicity, in vitro and in vivo
-
Fully compatible with Cap1 analogs, including LZCapā¢ AG(3āAcm)
A robust solution for high-purity, low-immunogenicity mRNA synthesis.
Why Visit Booth 5?
āļø Free giveaways
āļø In-depth technical consultations with our R&D team
āļø Discover how Yeasen can accelerate your mRNA pipeline
Letās shape the next generation of mRNA therapeuticsātogether.
Ā
Want to Learn More?
Canāt attend the summit? Weāve got you covered.
š© Contact us or request a sample today.
Website: www.yeasenbio.com
Email: info@yeasenbio.com
Ā
Additional Information
For more details, visit 5th Annual mRNA-Based Therapeutics Summit.
Ā